PE Tech Report

NEWSLETTER

Like this article?

Sign up to our free newsletter

Permira funds to partner with Marucci family

Funds advised by local private equity firm Permira, supported a co-investor, a wholly-owned subsidiary of the Abu Dhabi Investment Authority (ADIA), have entered into a partnership with Kedrion’s existing shareholders (the Marcucci family and FSI) to jointly acquire and combine Kedrion and BPL.

The combination will create a global player for medicines derived from human blood plasma, which treat patients with rare and life threatening conditions.
 
Kedrion, headquartered in Tuscany, Italy, brings an extensive portfolio of 21 products and over 600 marketing authorizations around the world. 
 
BPL, headquartered outside London, UK, operates a targeted portfolio of successful rare disease products and is one of the fastest growing players in the plasma industry. 

As a result of this transaction, the Permira funds will own a controlling stake in the combined business, which generates approximately EUR1.1 billion in annual revenues and employs in excess of 4,000 people worldwide.

Like this article? Sign up to our free newsletter

MOST POPULAR

FURTHER READING

Featured